AstraZeneca to Acquire Pearl Therapeutics to Strengthen Respiratory Portfolio

News   Jun 12, 2013

 
AstraZeneca to Acquire Pearl Therapeutics to Strengthen Respiratory Portfolio
 
 
 

RELATED ARTICLES

Sekisui XenoTech Hiring and Growing to Meet Customer Demand

News

Global contract research organization experiencing growth across all departments.

READ MORE

Innovative ALS Therapy Startup Wins Golden Ticket Funding From Amgen

News

Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.

READ MORE

Children With Congenital Zika Virus Infection Face Serious Challenges as They Age

News

The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE